Felbamate Tablet
Product Images NDC 70771-1077

2 FDA label images from Zydus Lifesciences Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Felbamate (NDC 70771-1077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

400 mg (785f1747 E29d 432a 82e7 Fcaeea202327 01)

400 mg (785f1747 E29d 432a 82e7 Fcaeea202327 01)
Felbamate Tablets, USP 400 mg oral tablets label from Zydus Lifesciences Limited. The package contains 100 tablets and is prescription only. It includes storage instructions, dosage reference, and a pharmacist dispensing note. Label also shows manufacturer address in Ahmedabad, India.*
FDA Label Image

600 mg (785f1747 E29d 432a 82e7 Fcaeea202327 02)

600 mg (785f1747 E29d 432a 82e7 Fcaeea202327 02)
Felbamate Tablets, USP 600 mg oral tablets in a package labeled for human prescription use. The label indicates 100 tablets per container, distributed by Zydus Lifesciences Ltd, Ahmedabad, India. The label includes dosage information, storage instructions, and a medication guide reference. The design features the product name prominently with the strength in a magenta box, along with a barcode on the left side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.